Paradigm Biopharmaceuticals Ltd. e tlalehile hore lithuto tsa pele li 'nile tsa etsoa ka nako e sa lekanyetsoang United States (US) tekong ea bohlokoa ea bongaka ea PARA_OA_002, ho hlahloba injectable pentosan polysulfate sodium (PPS/Zilosul®) bakeng sa phekolo ea bohloko bo amanang le knee osteoarthritis (kOA). ). Taba ea pele ea randomization e tiisitsoe Univesithing ea Northwestern, Chicago, ke Mofuputsi ea ka Sehloohong, Dr. Thomas Schnitzer MD, Ph.D.
Boithuto bo boholo lefatšeng ka bophara ba Phase III, PARA_OA_002, hajoale bo ntse bo hlahloba le ho ngolisa barupeluoa libakeng tse robeli ho pholletsa le Australia le libaka tse 21 ho tse 56 tse khethiloeng sebakeng sa liteko tsa US Clinical e 'nile ea tsepamisa maikutlo ho Paradigm ho tloha qalong ea selemo sa almanaka ho thusa. letamo le leholo la batho ba nang le bokhoni ba ho khetholloa ho pholletsa le libaka tse kentsoeng le ho qala ts'ebetso ea ho hlahloba. Ts'ebetso ea libaka tsa US e tla tsoela pele, 'me libaka tsa UK le EU le tsona li ntse li qalisoa ho pholletsa le CY22.
"Ho etsa hore lithuto tsa rona tsa pele li behoe ka linako tsohle Amerika ke mohato oa bohlokoa lenaneong la bongaka la OA. Sehlopha sa kliniki sa Paradigm se 'nile sa sebetsa ka thata ho qala le ho kenya libaka ho pholletsa le US,' me re bona palo e kholo ea batho ba kenang mokhahlelong oa ho hlahloba ho pholletsa le US. diketsahalo tsa bohlokwa ho beng ba diabo tsa rona,” ho boletse Ngaka Donna Skerrett, Ofisiri e ka Sehloohong ya Bongaka ya Paradigm le CEO wa Nakwana.
SEO U LOKELANG HO SE NKA HO SEHLOOHO ENA:
- The global pivotal Phase III, PARA_OA_002, study is currently screening and enrolling subjects in eight sites across Australia and 21 of the 56 selected sites in the U.
- Clinical trial site activation has been a critical focus for Paradigm from the start of the calendar year to enable a large pool of potential candidates to be identified across the activated sites and begin the screening process.
- The Paradigm clinical team has been working tirelessly to initiate and activate sites throughout the U.
